Valuation: Epigral Limited

Market Cap 44.44B 459M 410M 383M 348M 655M 660M 4.6B 1.8B 22.6B 1.72B 1.69B 72.65B P/E 2027 *
12.8x
P/E 2028 * 10.1x
Enterprise Value 50.35B 521M 465M 434M 394M 742M 748M 5.21B 2.04B 25.61B 1.95B 1.91B 82.32B EV / Sales 2027 *
1.63x
EV / Sales 2028 * 1.34x
Free-Float
31.14%
Yield 2027 *
0.53%
Yield 2028 * 0.53%
1 day+1.86%
1 week+1.78%
Current month+2.34%
1 month-15.04%
3 months+4.27%
6 months+14.92%
Current year-15.07%
1 week 975.9
Extreme 975.9
1,062
1 month 975.9
Extreme 975.9
1,215
Current year 807
Extreme 807
1,400
1 year 807
Extreme 807
1,730.7
3 years 807
Extreme 807
2,406.75
5 years 650
Extreme 650
2,406.75
10 years 387.1
Extreme 387.1
2,406.75
Manager TitleAgeSince
Chief Executive Officer 41 -
Director of Finance/CFO - 10/11/2025
Compliance Officer - 22/04/2024
Director TitleAgeSince
Director/Board Member 75 18/05/2017
Director/Board Member 43 05/10/2016
Director/Board Member 41 18/05/2017
Change 5-day change 1-year change 3-year change Capi.($)
+1.86%+1.78%-40.24%+5.02% 459M
-1.22%+1.97%+2.89%+29.57% 223B
-0.87%+0.40%+8.25%+27.73% 120B
-1.92%-2.56%-6.53%+23.60% 76.02B
+2.45%+18.62%+660.05%+348.70% 78.14B
-1.02%-0.04%+2.67%-1.05% 61.93B
-1.63%-0.56%-25.53%-44.15% 37.21B
+1.83%+1.83%+3.48%-21.99% 32.17B
+0.22%+0.22%+26.18%+57.06% 24.36B
-2.55%-3.79%-1.75%-26.68% 23.52B
Average -0.29%+0.99%+62.95%+39.78% 67.7B
Weighted average by Cap. -0.67%+1.63%+77.73%+55.12%

Financials

2027 *2028 *
Net sales 30.88B 319M 285M 266M 242M 455M 459M 3.2B 1.25B 15.7B 1.2B 1.17B 50.48B 37.28B 385M 344M 321M 292M 550M 554M 3.86B 1.51B 18.96B 1.45B 1.42B 60.94B
Net income 3.47B 35.82M 32.01M 29.86M 27.13M 51.09M 51.47M 359M 140M 1.76B 134M 132M 5.67B 4.4B 45.45M 40.61M 37.89M 34.42M 64.82M 65.3M 455M 178M 2.24B 171M 167M 7.19B
Net Debt 5.92B 61.16M 54.65M 50.99M 46.31M 87.22M 87.87M 613M 239M 3.01B 230M 225M 9.67B 5.49B 56.74M 50.69M 47.3M 42.96M 80.91M 81.51M 568M 222M 2.79B 213M 208M 8.97B
Projected Income Statement - Annual - Epigral Limited
Logo Epigral Limited
Epigral Limited is an India-based manufacturer of essential chemicals. The Company is engaged in the manufacturing and selling of chemicals, including derivatives and specialty chemicals. It operates under two businesses, Chlor-Alkali and Derivatives and Speciality chemicals, which relate to the manufacturing of Chlor-Alkali & its Derivatives. Chlor-Alkali is an industrial process that offers Sodium Hypochlorite, Hydrogen Gas, Caustic Soda Lye, Caustic Soda Flakes, and Liquid Chlorine. The Company offers a diverse portfolio of products, including chlorinated polyvinyl chloride (CPVC) Resin, CPVC Compound, Chlorotoluenes Value Chain, Epichlorohydrin, Chloromethanes, Hydrogen Peroxide, Caustic Soda, Chlorine, Hydrogen, and Caustic Potash. The Company caters to a range of industries such as refineries, paper and pulp, fluoropolymers, soaps & detergents, textiles, dyes & pigment, pharmaceuticals, agrochemicals, paints and coating, refrigerant gas, electronics, water treatment, and others.
Employees
1,135
Date Price Change Volume
07/10/26 ₹1,030.00 -0.60% 47,054
06/10/26 ₹1,036.20 +1.86% 67,127
05/10/26 ₹1,017.30 +3.57% 60,534
01/10/26 ₹982.20 -2.99% 80,328
30/09/26 ₹1,012.50 -0.55% 37,182
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Epigral Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,030.00INR
Average target price
1,728.00INR
Spread / Average Target
+67.77%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Epigral Limited
  1. Stock Market
  2. Stocks
  3. EPIGRAL Stock